Verinnogen raises €288K Pre-Seed round

22 November 2022· Cambridge, United Kingdom· health, oncology, biotech, ai, b2b, software_hardware

Verinnogen joined the Start Codon accelerator to receive an initial investment and mentorship to develop its hand-held 3D surface profiling technology for cancer research.

Investors

LeadStart Codon

About Verinnogen

Stage
Pre-Seed
Headquarters
Cambridge, United Kingdom
Founded
2021
Team Size
6–20
Sectors
healthoncologybiotechaib2bsoftware_hardware

Source: https://verinnogen.com/news